JP2011525388A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011525388A5 JP2011525388A5 JP2011514898A JP2011514898A JP2011525388A5 JP 2011525388 A5 JP2011525388 A5 JP 2011525388A5 JP 2011514898 A JP2011514898 A JP 2011514898A JP 2011514898 A JP2011514898 A JP 2011514898A JP 2011525388 A5 JP2011525388 A5 JP 2011525388A5
- Authority
- JP
- Japan
- Prior art keywords
- delivery system
- eye
- latanoprost
- punctal plug
- days
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 25
- GGXICVAJURFBLW-CEYXHVGTSA-N latanoprost Chemical compound CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1 GGXICVAJURFBLW-CEYXHVGTSA-N 0.000 claims 21
- 229960001160 latanoprost Drugs 0.000 claims 21
- 230000004410 intraocular pressure Effects 0.000 claims 11
- 241000083513 Punctum Species 0.000 claims 10
- 238000013268 sustained release Methods 0.000 claims 9
- 239000012730 sustained-release form Substances 0.000 claims 9
- 239000003814 drug Substances 0.000 claims 7
- 208000010412 Glaucoma Diseases 0.000 claims 6
- 239000003889 eye drop Substances 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 4
- 229940079593 drug Drugs 0.000 claims 3
- 238000009472 formulation Methods 0.000 claims 3
- 150000003180 prostaglandins Chemical class 0.000 claims 3
- 229920002988 biodegradable polymer Polymers 0.000 claims 2
- 239000004621 biodegradable polymer Substances 0.000 claims 2
- 239000011159 matrix material Substances 0.000 claims 2
- 239000013589 supplement Substances 0.000 claims 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical class CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 claims 1
- 201000002862 Angle-Closure Glaucoma Diseases 0.000 claims 1
- 206010030348 Open-Angle Glaucoma Diseases 0.000 claims 1
- 239000000695 adrenergic alpha-agonist Substances 0.000 claims 1
- 229940006133 antiglaucoma drug and miotics carbonic anhydrase inhibitors Drugs 0.000 claims 1
- 239000002876 beta blocker Substances 0.000 claims 1
- 229940097320 beta blocking agent Drugs 0.000 claims 1
- 239000003489 carbonate dehydratase inhibitor Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000006196 drop Substances 0.000 claims 1
- 230000004406 elevated intraocular pressure Effects 0.000 claims 1
- 230000037431 insertion Effects 0.000 claims 1
- 238000003780 insertion Methods 0.000 claims 1
- 230000003547 miosis Effects 0.000 claims 1
- 239000003604 miotic agent Substances 0.000 claims 1
- 229920001296 polysiloxane Polymers 0.000 claims 1
- 201000006366 primary open angle glaucoma Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7528408P | 2008-06-24 | 2008-06-24 | |
| US61/075,284 | 2008-06-24 | ||
| PCT/US2009/048452 WO2010008883A1 (en) | 2008-06-24 | 2009-06-24 | Combination treatment of glaucoma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011525388A JP2011525388A (ja) | 2011-09-22 |
| JP2011525388A5 true JP2011525388A5 (enExample) | 2012-08-02 |
Family
ID=41431875
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011514898A Pending JP2011525388A (ja) | 2008-06-24 | 2009-06-24 | 緑内障の併用治療 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20090318549A1 (enExample) |
| EP (1) | EP2303184A4 (enExample) |
| JP (1) | JP2011525388A (enExample) |
| CN (1) | CN102105118A (enExample) |
| CA (1) | CA2728623A1 (enExample) |
| TW (1) | TW201012469A (enExample) |
| WO (1) | WO2010008883A1 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101052435B (zh) | 2004-07-02 | 2010-12-08 | Qlt塞子传递公司 | 治疗介质递送装置 |
| ES2640458T3 (es) | 2006-03-31 | 2017-11-03 | Mati Therapeutics Inc. | Implantes del sistema de drenaje nasolagrimal para terapia medicamentosa |
| EP3372205A1 (en) | 2007-09-07 | 2018-09-12 | Mati Therapeutics Inc. | Lacrimal implant detection |
| BRPI0912182A2 (pt) * | 2008-05-09 | 2015-10-06 | Qlt Plug Delivery Inc | distribuição de liberação prolongada de agentes ativos pára tratar glaucoma e hipertensão ocular |
| JP5695035B2 (ja) | 2009-06-03 | 2015-04-01 | フォーサイト・ビジョン５・インコーポレイテッドＦｏｒｓｉｇｈｔ Ｖｉｓｉｏｎ５，Ｉｎｃ． | 前眼部薬物供給 |
| SG187770A1 (en) | 2010-08-12 | 2013-03-28 | Univ Nanyang Tech | A liposomal formulation for ocular drug delivery |
| US8591484B2 (en) | 2010-09-15 | 2013-11-26 | AlphaMed, Inc. | Lacrimal punctum measurement and occlusion |
| US20120312840A1 (en) * | 2011-05-13 | 2012-12-13 | Ayako Hasegawa | Container closure system with integral antimicrobial additives |
| US9974685B2 (en) | 2011-08-29 | 2018-05-22 | Mati Therapeutics | Drug delivery system and methods of treating open angle glaucoma and ocular hypertension |
| DK3290024T3 (da) | 2011-08-29 | 2019-06-03 | Mati Therapeutics Inc | Vedvarende indgivelse af aktive midler til behandling af glaukom og okulær hypertension |
| ES2912370T3 (es) | 2011-09-14 | 2022-05-25 | Forsight Vision5 Inc | Aparato para inserción ocular |
| CN104884006B (zh) | 2012-10-26 | 2017-12-15 | 弗赛特影像5股份有限公司 | 用于持续释放药物到眼睛的眼科系统 |
| WO2014117010A2 (en) * | 2013-01-24 | 2014-07-31 | Rigel Pharmaceuticals, Inc. | Composition for ophthalmic administration |
| US9956195B2 (en) | 2014-01-07 | 2018-05-01 | Nanyang Technological University | Stable liposomal formulations for ocular drug delivery |
| US9424722B2 (en) * | 2014-05-14 | 2016-08-23 | Unlimited Liability, LLC | Smart memory material lock devices |
| US20170266391A1 (en) * | 2014-09-22 | 2017-09-21 | Kaneka Corporation | Injection needle device for endoscope |
| KR102511830B1 (ko) * | 2014-11-25 | 2023-03-17 | 엑시모어 엘티디. | 단일 및 다수 생체활성제를 전달하기 위한 조성물 및 방법 |
| WO2016168141A1 (en) | 2015-04-13 | 2016-10-20 | Forsight Vision5, Inc. | Ocular insert composition of semi-crystalline or crystalline pharmaceutically active agent |
| US11291847B2 (en) * | 2015-06-16 | 2022-04-05 | The Regents Of The University Of Colorado, A Body Corporate | Systems and methods for preventing, diagnosing, and/or treating one or more medical conditions via neuromodulation |
| CN105879126A (zh) * | 2016-03-24 | 2016-08-24 | 杭州亚慧生物科技有限公司 | 一种超润滑血清白蛋白泪点塞及其制备方法 |
| AU2019245436B2 (en) * | 2018-03-29 | 2024-12-12 | Mati Therapeutics Inc. | Ophthalmic drug sustained release formulation and uses for dry eye syndrome treatment |
| CN109568138B (zh) * | 2019-01-10 | 2021-06-25 | 新疆国际旅行卫生保健中心 | 药片分割装置 |
| US12447045B2 (en) | 2019-10-02 | 2025-10-21 | Segal Innovations LLC | Bio-adhesive dissolving compounds and device |
| US11207267B2 (en) | 2019-10-02 | 2021-12-28 | Segal Innovations LLC | Bio-adhesive dissolving compounds and device |
| JP2024508811A (ja) | 2021-02-24 | 2024-02-28 | オキュラ セラピューティクス，インコーポレイテッド | 小管内デポーインサータ装置 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4281654A (en) * | 1980-04-07 | 1981-08-04 | Alza Corporation | Drug delivery system for controlled ocular therapy |
| US5589563A (en) * | 1992-04-24 | 1996-12-31 | The Polymer Technology Group | Surface-modifying endgroups for biomedical polymers |
| DK0637323T3 (da) * | 1992-04-24 | 1999-05-25 | Polymer Technology Group Inc | Copolymerer og ikke-porøs, semipermeabel membran deraf og dens anvendelse til permeering af molekyler med et forudbestemt m |
| US6196993B1 (en) * | 1998-04-20 | 2001-03-06 | Eyelab Group, Llc | Ophthalmic insert and method for sustained release of medication to the eye |
| ES2172415B2 (es) * | 2000-07-28 | 2003-11-16 | Univ Madrid Complutense | Tratamiento del glaucoma y la hipertension ocular por medio de un analogo de la melatonina. |
| US6534693B2 (en) * | 2000-11-06 | 2003-03-18 | Afmedica, Inc. | Surgically implanted devices having reduced scar tissue formation |
| WO2004066979A2 (en) * | 2003-01-24 | 2004-08-12 | Control Delivery Systems, Inc. | Sustained release device and method for ocular delivery of adrenergic agents |
| EP1603485A4 (en) * | 2003-02-26 | 2011-03-30 | Medivas Llc | BIOACTIVE STENTS AND METHOD OF USE THEREOF |
| US7662864B2 (en) * | 2003-06-04 | 2010-02-16 | Rutgers, The State University Of New Jersey | Solution polymerization processes to prepare a polymer that degrades to release a physiologically active agent |
| US20050129731A1 (en) * | 2003-11-03 | 2005-06-16 | Roland Horres | Biocompatible, biostable coating of medical surfaces |
| US20050232972A1 (en) * | 2004-04-15 | 2005-10-20 | Steven Odrich | Drug delivery via punctal plug |
| US7799336B2 (en) * | 2004-04-30 | 2010-09-21 | Allergan, Inc. | Hypotensive lipid-containing biodegradable intraocular implants and related methods |
| JP2009511604A (ja) * | 2005-10-14 | 2009-03-19 | アルコン，インコーポレイテッド | 緑内障の原発性形態および続発性形態を処置するための方法 |
| ES2640458T3 (es) * | 2006-03-31 | 2017-11-03 | Mati Therapeutics Inc. | Implantes del sistema de drenaje nasolagrimal para terapia medicamentosa |
| JP5323720B2 (ja) * | 2006-12-18 | 2013-10-23 | アルコン リサーチ， リミテッド | 眼用薬物送達のためのデバイスおよび方法 |
| UY30883A1 (es) * | 2007-01-31 | 2008-05-31 | Alcon Res | Tapones punctales y metodos de liberacion de agentes terapeuticos |
| NZ598483A (en) * | 2007-09-07 | 2013-08-30 | Quadra Logic Tech Inc | Drug cores for sustained release of therapeutic agents |
| KR20100058620A (ko) * | 2007-09-07 | 2010-06-03 | 큐엘티 플러그 딜리버리, 인코포레이티드 | 눈물 임플랜트용 삽입 및 적출 기구 |
| CA2698508C (en) * | 2007-09-07 | 2017-06-06 | Alan R. Rapacki | Lacrimal implants and related methods |
| RU2010136822A (ru) * | 2008-02-18 | 2012-03-10 | Клт Плаг Диливери, Инк. (Us) | Лакримальные имплантаты и связанные с ними способы |
| JP5552482B2 (ja) * | 2008-04-30 | 2014-07-16 | キュー エル ティー インク． | 複合涙管挿入物および関連する方法 |
| BRPI0912182A2 (pt) * | 2008-05-09 | 2015-10-06 | Qlt Plug Delivery Inc | distribuição de liberação prolongada de agentes ativos pára tratar glaucoma e hipertensão ocular |
-
2009
- 2009-06-24 TW TW098121236A patent/TW201012469A/zh unknown
- 2009-06-24 JP JP2011514898A patent/JP2011525388A/ja active Pending
- 2009-06-24 US US12/490,923 patent/US20090318549A1/en not_active Abandoned
- 2009-06-24 CA CA2728623A patent/CA2728623A1/en not_active Abandoned
- 2009-06-24 CN CN2009801288704A patent/CN102105118A/zh active Pending
- 2009-06-24 EP EP09798519.6A patent/EP2303184A4/en not_active Withdrawn
- 2009-06-24 WO PCT/US2009/048452 patent/WO2010008883A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011525388A5 (enExample) | ||
| NZ588938A (en) | Sustained release delivery of active agents to treat glaucoma and ocular hypertension | |
| Chang | Use of Malyugin pupil expansion device for intraoperative floppy-iris syndrome: results in 30 consecutive cases | |
| JP2011520805A5 (enExample) | ||
| Grob et al. | Management of mydriasis and pain in cataract and intraocular lens surgery: review of current medications and future directions | |
| Yellepeddi et al. | Punctal plug: a medical device to treat dry eye syndrome and for sustained drug delivery to the eye | |
| Miller et al. | Medical anti‐glaucoma therapy: Beyond the drop | |
| JP2016028091A5 (enExample) | ||
| JP2019532931A (ja) | 眼瞼炎の治療に使用するための医薬組成物 | |
| WO2010085696A3 (en) | Sustained released delivery of one or more agents | |
| JP2008538215A5 (enExample) | ||
| CA3045733A1 (en) | Compositions comprising tacrolimus for the treatment of intraocular inflammatory eye diseases | |
| CA2648066A1 (en) | Drug delivery methods, structures, and compositions for nasolacrimal system | |
| ES2649730T3 (es) | Distribución craneal de compuestos farmacéuticos | |
| JP2021059554A (ja) | 増殖性硝子体網膜症用メトトレキサート | |
| WO2012092510A3 (en) | Ocular drug delivery system | |
| JP2016121163A (ja) | 眼内でのコルチコステロイド使用に伴う眼圧の発生を減少させる方法 | |
| Uña et al. | Perioperative pharmacological management in patients with glaucoma | |
| JP2015520628A5 (enExample) | ||
| KR20240050324A (ko) | 빈포세틴을 사용한 근시치료방법 | |
| WO2011163356A2 (en) | Methods of treating conditions associated with overactive bladder | |
| Higginbotham | Will latanoprost be the'wonder'drug of the'90s for the treatment of glaucoma? | |
| Sheth et al. | Traumatic aniridia after small incision cataract extraction | |
| Au et al. | XEN Gel Implant | |
| Gagliardi et al. | Two cases of therapeutic scleral lenses for KID syndrome |